Transplanted bone marrow endothelial progenitor cells delay ALS disease progression

Transplantation of human bone marrow-derived endothelial progenitor cells (EPCs) into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier (BSCB), University of South Florida researchers report.

From https://medicalxpress.com/news/2019-04-transplanted-bone-marrow-endothelial-progenitor.html

from
https://healthnews010.wordpress.com/2019/04/03/transplanted-bone-marrow-endothelial-progenitor-cells-delay-als-disease-progression/

From https://heidifrost.blogspot.com/2019/04/transplanted-bone-marrow-endothelial.html

from
https://heidifrost0.wordpress.com/2019/04/03/transplanted-bone-marrow-endothelial-progenitor-cells-delay-als-disease-progression/

From https://kathrynhenson0.blogspot.com/2019/04/transplanted-bone-marrow-endothelial.html

from
https://kathrynhenson0.wordpress.com/2019/04/03/transplanted-bone-marrow-endothelial-progenitor-cells-delay-als-disease-progression/

From https://kathleenwood0.blogspot.com/2019/04/transplanted-bone-marrow-endothelial.html

from
https://kathleenwood0.wordpress.com/2019/04/03/transplanted-bone-marrow-endothelial-progenitor-cells-delay-als-disease-progression/

From https://tiarablair1.blogspot.com/2019/04/transplanted-bone-marrow-endothelial.html

from
https://tiarablair.wordpress.com/2019/04/03/transplanted-bone-marrow-endothelial-progenitor-cells-delay-als-disease-progression/